Managed Healthcare Executive

A Potential First-in-Class Treatment Shows Improvement in a Rare Type of Narcolepsy

Narcolepsy type 1 is a chronic, rare neurological disease caused by the loss of orexin neurons in the brain. Orexin is a ...

FDA recalls blood pressure medicine over cancerous chemical

More than half a million bottles of blood pressure medication are being recalled over a cancer-causing chemical connected to ...
Everyday Health on MSN

Walmart to Offer Discounted GLP-1 Drugs, Following Costco, Sam’s Club, and CVS

Walmart is joining Costco, Sam’s Club, and CVS in offering cheaper prices for customers paying out of pocket for Zepbound, ...
India Today on MSN

First GLP-1 drug approved to protect against heart attacks, stroke

The FDA has approved Rybelsus, the first oral GLP-1 receptor agonist, to reduce cardiovascular risk in type 2 diabetes ...
FOX 5 Atlanta

Blood pressure medication recalled due to cancerous chemical

More than 500,000 bottles of blood pressure medication have been recalled for having high levels of a cancer-causing chemical ...

Blood pressure medicine recalled over cancer-causing chemical concerns

Pharmaceutical company issues voluntary recall for blood pressure medication over cancer-causing chemical being found in the ...

China's Innovent says its GLP-1 works better than Novo's semaglutide in diabetes study

China's Innovent Biologics saidon Monday its GLP-1 injection led to more weight loss and better control of blood sugar in ...
Morningstar

Lilly's oral GLP-1, orforglipron, demonstrated meaningful weight loss and cardiometabolic improvements in complete ATTAIN-1 results published in The New England Journal of Medicine

iControlled for family-wise type 1 error rate. iiPercentage of participants achieving body weight reductions of ≥20% with orforglipron 6 mg was not controlled for ...